{"id":58286,"date":"2024-06-05T08:00:00","date_gmt":"2024-06-05T06:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/ipsen-presents-long-term-elafibranor-efficacy-and-itch-related-quality-of-life-data-in-patients-with-primary-biliary-cholangitis\/"},"modified":"2024-07-23T10:23:53","modified_gmt":"2024-07-23T08:23:53","slug":"ipsen-presents-long-term-elafibranor-efficacy-and-itch-related-quality-of-life-data-in-patients-with-primary-biliary-cholangitis","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/press-releases\/ipsen-presents-long-term-elafibranor-efficacy-and-itch-related-quality-of-life-data-in-patients-with-primary-biliary-cholangitis\/","title":{"rendered":"Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis\u00a0\u00a0\u00a0\u00a0"},"content":{"rendered":"